Jared Laino, PA-C

NPI: 1568981538
Total Payments
$7,912
2024 Payments
$1,964
Companies
28
Transactions
462
Medicare Patients
1,208
Medicare Billing
$124,486

Payment Breakdown by Category

Food & Beverage$7,865 (99.4%)
Education$46.91 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,865 461 99.4%
Education $46.91 1 0.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,111 77 $0 (2024)
Teva Pharmaceuticals USA, Inc. $759.49 58 $0 (2024)
Alkermes, Inc. $698.53 28 $0 (2024)
ITI, Inc. $677.34 31 $0 (2023)
Vanda Pharmaceuticals Inc. $575.34 39 $0 (2024)
Otsuka America Pharmaceutical, Inc. $570.91 27 $0 (2023)
Janssen Pharmaceuticals, Inc $559.10 25 $0 (2024)
Supernus Pharmaceuticals, Inc. $550.15 32 $0 (2024)
Neurocrine Biosciences, Inc. $484.81 23 $0 (2024)
EISAI INC. $286.68 24 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,964 73 Alkermes, Inc. ($304.48)
2023 $1,983 99 ABBVIE INC. ($436.48)
2022 $3,110 223 ITI, Inc. ($461.74)
2021 $854.68 67 Eisai Inc. ($244.78)

All Payment Transactions

462 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
12/20/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $20.14 General
Category: Neuroscience
12/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug), HETLIOZ Food and Beverage In-kind items and services $7.13 General
Category: SCHIZOPHRENIA
12/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.03 General
Category: NEUROSCIENCE
12/13/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $11.35 General
Category: Neuropsychiatry
12/12/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $14.42 General
Category: CNS
12/10/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $18.07 General
Category: Psychiatry/Psychology
12/09/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $6.51 General
Category: Central Nervous System
11/26/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $25.97 General
Category: PSYCHIATRY
11/20/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $114.08 General
Category: Neuropsychiatry
11/15/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $21.14 General
Category: Neuroscience
11/11/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $132.38 General
Category: Psychiatry/Psychology
11/11/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $6.10 General
Category: Psychiatry/Psychology
11/08/2024 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $10.43 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
10/31/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $15.67 General
Category: PSYCHIATRY
10/26/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $17.83 General
Category: Neuropsychiatry
10/25/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $5.52 General
Category: Neuropsychiatry
10/24/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.97 General
Category: NEUROSCIENCE
10/22/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.71 General
Category: PSYCHIATRY
10/17/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $8.69 General
Category: CNS
10/16/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $118.54 General
Category: CNS
10/16/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $14.14 General
Category: NEUROSCIENCE
10/11/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $6.72 General
Category: Central Nervous System
10/10/2024 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $12.16 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
10/07/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $15.80 General
Category: VILOXAZINE HYDROCHLORIDE
10/03/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $5.94 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 107 213 $27,079 $10,482
2022 3 261 726 $106,425 $40,222
2021 5 435 780 $118,000 $48,471
2020 4 405 592 $80,131 $25,310
Total Patients
1,208
Total Services
2,311
Medicare Billing
$124,486
Procedure Codes
15

All Medicare Procedures & Services

15 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 75 155 $19,646 $5,951 30.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 43 $5,402 $2,946 54.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 15 15 $2,031 $1,585 78.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 189 598 $77,740 $28,837 37.1%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 55 55 $15,180 $6,156 40.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 17 73 $13,505 $5,229 38.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 283 558 $72,540 $29,269 40.3%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 80 80 $22,080 $9,459 42.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 31 66 $12,210 $5,558 45.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 24 41 $6,970 $2,525 36.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 17 35 $4,200 $1,662 39.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 328 492 $63,440 $19,747 31.1%
90792 Psychiatric diagnostic evaluation with medical services Office 2020 44 44 $12,083 $3,930 32.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 13 29 $3,480 $1,409 40.5%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 20 27 $1,128 $224.17 19.9%

About Jared Laino, PA-C

Jared Laino, PA-C is a Physician Assistant healthcare provider based in New Bern, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2017. The National Provider Identifier (NPI) number assigned to this provider is 1568981538.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jared Laino, PA-C has received a total of $7,912 in payments from pharmaceutical and medical device companies, with $1,964 received in 2024. These payments were reported across 462 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($7,865).

As a Medicare-enrolled provider, Laino has provided services to 1,208 Medicare beneficiaries, totaling 2,311 services with total Medicare billing of $124,486. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Other Specialties Medical
  • Location New Bern, NC
  • Active Since 09/11/2017
  • Last Updated 07/26/2023
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1568981538

Products in Payments

  • VRAYLAR (Drug) $1,111
  • CAPLYTA (Drug) $842.62
  • REXULTI (Drug) $563.32
  • QELBREE (Drug) $534.35
  • INGREZZA (Drug) $484.81
  • HETLIOZ (Drug) $413.93
  • ARISTADA (Drug) $363.63
  • LYBALVI (Drug) $334.90
  • SPRAVATO (Drug) $291.41
  • Dayvigo (Drug) $286.68
  • INVEGA SUSTENNA (Drug) $267.69
  • UZEDY (Drug) $254.88
  • AUSTEDO (Drug) $231.74
  • Austedo XR (Drug) $220.72
  • FANAPT (Drug) $161.41
  • COBENFY (Drug) $156.55
  • BELSOMRA (Drug) $153.75
  • CITALOPRAM (Drug) $115.82
  • ABILIFY MAINTENA (Drug) $114.38
  • NUEDEXTA (Drug) $95.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in New Bern